Replies to post #5119 on Sesen Bio Inc (SESN)

[grich1]

As soon as I noticed they were reporting the 12 month data, I figured it was going to be a bad day.
Lack of DD by some not understanding the indication and strategy to get into market with second line with goal to replace BCG.

I’m confident drug will get approved based upon safety record compared to peers.